Sep 1, 2022
In this episode – part four of AHA’s five-part series on opioid stewardship – Marie Cleary-Fishman, AHA’s vice president of clinical quality, is joined once again by Holly Geyer, M.D., hospital internal medicine practitioner subspecialized in addiction medicine at Mayo Clinic. The discussion:…
Aug 31, 2022
America has seen soaring rates of fatal overdoses from opioid analgesics – that is prescription drugs such as oxycodone, hydrocodone and fentanyl, a synthetic opioid that is often produced and sold illegally.
Jul 13, 2022
Marie Cleary-Fishman, speaks with Holly Geyer, M.D., about the roots of the opioid epidemic and the state and federal requirements — and institutional protocols — for developing solutions.
Jul 13, 2022
The opioid crisis has been around for decades and has progressively worsen during the pandemic.
Jul 6, 2022
During the past two years, the health care field has been focused on fighting COVID-19…as it should be. Yet at the same time, another crisis surges.
Jun 21, 2022
Organizations can apply through July 29 for a portion of $10 million in funding to expand access to medication-assisted treatment for opioid use disorder in rural communities, the HRSA announced.
Apr 28, 2022
Reduce barriers to naloxone access. Put it in the hands of patients, families, friends, law enforcement officers and anyone hoping for the chance to be a Good Samaritan.
Apr 21, 2022
The agency seeks comments through June 21 on a potential change that would require outpatient settings to dispense opioid pain medications with prepaid mail-back envelopes and pharmacists to provide patient education on safe disposal of opioids.
Apr 7, 2022
In this webinar, Hazelden Betty Ford’s Stephen Delisi, MD, will examine the growing rates of substance use disorder and the impact of opioids and fentanyl on communities through his role consulting with health systems and medical professionals across the country. To focus on one health system’s…
Mar 15, 2022
The Substance Abuse and Mental Health Services Administration announced $25.6 million in grants to expand access to medication-assisted treatment for opioid use disorder and prevent the misuse of prescription drugs.